Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.98M | 3.69M | 5.47M | 4.33M | 23.35M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 246.00K | 344.00K | 479.00K | 729.00K | 855.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.00K | 158.00K | 158.00K | 158.00K | 158.00K |
| Total Current Assets | 2.25M | 4.19M | 6.11M | 5.22M | 24.36M |
|
|
|||||
| Total Current Assets | 2.25M | 4.19M | 6.11M | 5.22M | 24.36M |
| Net Property, Plant & Equipment | 18.00K | 25.00K | 37.00K | 49.00K | 73.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.47M | 5.77M | 6.07M | 6.38M | 6.68M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 32.00K |
| Total Assets | 7.74M | 9.99M | 12.22M | 11.64M | 31.14M |
|
|
|||||
| Total Accounts Payable | 1.48M | 1.16M | 291.00K | 392.00K | 1.58M |
| Total Accrued Expenses | 1.50M | 926.00K | 993.00K | 1.22M | 2.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 7.89M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.98M | 2.09M | 1.28M | 1.62M | 12.43M |
|
|
|||||
| Total Current Liabilities | 2.98M | 2.09M | 1.28M | 1.62M | 12.43M |
| Long-Term Debt | -- | -- | -- | -- | 5.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.64M | 1.62M | 1.60M | 1.57M | 1.55M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.62M | 3.71M | 2.88M | 3.19M | 19.01M |
|
|
|||||
| Common Stock & APIC | 453.08M | 452.43M | 451.57M | 447.39M | 445.84M |
| Retained Earnings | -449.96M | -446.14M | -442.24M | -438.94M | -433.73M |
| Treasury Stock & Other | -- | -- | -- | 8.00K | 16.00K |
| Total Common Equity | 3.12M | 6.28M | 9.34M | 8.45M | 12.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
|
|
|||||
| Total Common Equity | 3.12M | 6.28M | 9.34M | 8.45M | 12.13M |
| Total Preferred Equity | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.12M | 6.28M | 9.34M | 8.45M | 12.13M |
|
|
|||||